Pelvic lymph node decidua mimicking metastatic cervical cancer in pregnancyKrista S Pfaendler, H James Williams
6 June 2022
Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit StudyYeh Chen Lee, Madeleine T King, Rachel L O'Connell, Anne Lanceley, Florence Joly, Felix Hilpert, Alison Davis, Felicia T Roncolato, Aikou Okamoto, Jane Bryce, Paul Donnellan, Amit M Oza, Elisabeth Avall-Lundqvist, Jonathan S Berek, Jonathan A LedermannSee the full list of authors
27 January 2022
Screening and risk reducing surgery for endometrial or ovarian cancers in Lynch syndrome: a systematic reviewNatalie Lim, Martha Hickey, Graeme P Young, Finlay A Macrae, Christabel Kelly
18 April 2022
Disparity of ovarian cancer survival between urban and rural settingsKeely Krolikowski Ulmer, Breanna Greteman, Nicholas Cardillo, Anthony Schneider, Megan McDonald, David Bender, Michael J Goodheart, Jesus Gonzalez Bosquet
23 February 2022
The role of hyperthermia in the treatment of locally advanced cervical cancer: a comprehensive reviewMarloes IJff, Johannes Crezee, Arlene L Oei, Lukas J A Stalpers, Henrike Westerveld
19 January 2022
Updates in the treatment of vaginal cancerAnuja Jhingran
7 March 2022
Global challenges of radiotherapy for the treatment of locally advanced cervical cancerJyoti S Mayadev, Guihao Ke, Umesh Mahantshetty, Marcos David Pereira, Rafal Tarnawski, Takafumi Toita
7 March 2022
Centralized surveillance of hydatidiform mole: 7-year experience from a regional hospital in ChinaLanzhou Jiao, Yaping Wang, Jiyong Jiang, Xiuying Wang, Wenqing Zhang, Chenggong Zhu, Yang Xiang
19 November 2021
Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-001Christian Marth, Rafal Tarnawski, Alexandra Tyulyandina, Sandro Pignata, Lucy Gilbert, Diego Kaen, M Jesús Rubio, Sophia Frentzas, Mario Beiner, Manuel Magallanes-Maciel, Laura Farrelly, Chel Hun Choi, Regina Berger, Christine Lee, Christof VulstekeSee the full list of authors
19 November 2021
ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA–MONO) and rucaparib in combination with nivolumab (ATHENA–COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancerBradley J Monk, Robert L Coleman, Keiichi Fujiwara, Michelle K Wilson, Amit M Oza, Ana Oaknin, David M O’Malley, Domenica Lorusso, Shannon N Westin, Tamar Safra, Thomas J Herzog, Frederik Marmé, Ramez N Eskander, Kevin K Lin, Danny ShihSee the full list of authors
30 September 2021